Abstract

Background The pathogenic variant, POU class 4 transcription factor 3 (POU4F3), is reported to cause autosomal dominant nonsyndromic hearing loss (ADNSHL). Previously, we have examined a four-generation midfrequency sensorineural hearing loss (MFSNHL) family (no. 6126) and established POU4F3 c.602T>C (p.Leu201Pro) as a potential disease-causing variant. Objectives We explored the structural and functional alterations that the c.602T>C (p.Leu201Pro) variant enforces on the POU4F3 protein. Methods We utilized wild-type (WT) and mutant (MUT) POU4F3 c.602T>C plasmid incorporation into HeLa cells to assess functional changes, by immunofluorescence and luciferase assays. To predict protein structural alterations in the MUT versus WT POU4F3, we also generated 3D structures to compare both types of POU4F3 proteins. Results The WT POU4F3 is ubiquitously present in the nucleus, whereas the MUT form of POU4F3 exhibits a more restricted nuclear presence. This finding is different from other publications, which report a cytoplasmic localization of the MUT POU4F3. We also demonstrated that, as opposed to WT POU4F3, the MUT POU4F3 had 40% reduced luciferase activity. Conclusions The reduced nuclear presence, combined with reduced transcriptional activity, suggests that the POU4F3 c.602T>C variant alters cellular activity and may contribute to the pathogenicity of POU4F3-related hearing loss. It, also, provides more evidence of the pathophysiological characteristics of MFSNHL.

Highlights

  • Midfrequency sensorineural hearing loss (MFSNHL) is a severe condition that can affect hearing and speech at an early stage

  • 7 genes have been identified in relation to this condition: TECTA, OTOA, EYA4, COL11A2, CCDC50, POU class 4 transcription factor 3 (POU4F3), and SLC44A4 [1,2,3,4,5,6,7]

  • POU4F3 acts as a transcription factor that interacts with and modulates the expression of targetspecific genes [11, 12]

Read more

Summary

Introduction

Midfrequency sensorineural hearing loss (MFSNHL) is a severe condition that can affect hearing and speech at an early stage. 7 genes have been identified in relation to this condition: TECTA, OTOA, EYA4, COL11A2, CCDC50, POU4F3, and SLC44A4 [1,2,3,4,5,6,7] Mutational analysis of these genes can be used in a clinical setting to aid in the molecular diagnosis of MFSNHL. We examined the effects of the POU4F3 heterozygous variant c.602T>C (p.Leu201Pro) in terms of protein localization and function, using wild-type (WT) and mutant (MUT) POU4F3 EGFP expression vectors. The reduced nuclear presence, combined with reduced transcriptional activity, suggests that the POU4F3 c.602T>C variant alters cellular activity and may contribute to the pathogenicity of POU4F3-related hearing loss. Provides more evidence of the pathophysiological characteristics of MFSNHL

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call